Eli Lilly shares jump after company says it's seeking FDA clearance for antibody drug

Shares of Eli Lilly rose on Wednesday after the company announced it submitted a request the U.S. FDA for emergency authorization of its Covid-19 antibody treatment.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.